Evidence map›Paper›PMID 40958148›Full record

ReviewTransplantation2026

Unique Immune Polarization of the Lung Allograft: Implications for Organ-specific Immunoregulation and Tolerance Induction.

Erica Leyder, Mojtaba Taheri, Michael Neschis, Anirban Banerjee, Elizabeth A Jacobsen, Andrew Gelman, Daniel Kreisel, Alexander Sasha Krupnick, Zhongcheng Mei

Abstract readReview
In one paragraph

Review in Transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Erica LeyderDepartment of Surgery, University of Maryland Medical Center, Baltimore, MD.
Mojtaba TaheriDepartment of Surgery, University of Maryland Medical Center, Baltimore, MD.
Michael NeschisDepartment of Surgery, University of Maryland Medical Center, Baltimore, MD.
Anirban BanerjeeDepartment of Surgery, University of Maryland Medical Center, Baltimore, MD.
Elizabeth A JacobsenDivision of Allergy, Asthma and Clinical Immunology, Mayo Clinic, Scottsdale, AZ.
Andrew GelmanDepartment of Pathology & Immunology, Washington University, St. Louis, MO.
Daniel KreiselDepartment of Pathology & Immunology, Washington University, St. Louis, MO.
Alexander Sasha KrupnickDepartment of Surgery, University of Maryland Medical Center, Baltimore, MD.
Zhongcheng MeiDepartment of Surgery, University of Maryland Medical Center, Baltimore, MD.

Funding

The Role of Neutrophils in Regulating Lung Transplant ToleranceP01AI116501 · NIAID · WASHINGTON UNIVERSITY · PI ALEXANDER S. KRUPNICK · 2015 to 2026
$19.4M
The Role of Eosinophils in the Lung AllograftR01AI145108 · NIAID · UNIVERSITY OF VIRGINIA · PI Elizabeth A Jacobsen, ALEXANDER S. KRUPNICK · 2019 to 2026
$4.1M
Targeting a Defined Surgical Stress-Induced Inflammatory Pathway to Improve Peri-Operative OutcomesR01HL166402 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI Elizabeth A Jacobsen, ALEXANDER S. KRUPNICK · 2023 to 2026
$2.2M
BLRD VA I01 BX002299NHLBI NIH HHS R01 HL166402NIAID NIH HHS P01 AI116501NIAID NIH HHS R01 AI145108
6 · The paper itself

Abstract

Technological innovations have improved many barriers in lung transplantation, but high rates of acute and chronic rejection still limit lung allograft survival. This may be explained by the unique environment of the lung. As a mucosal barrier organ, the lung is constantly exposed to the external environment, leading to unique immunological features that are not seen in other transplantable solid organ allografts such as hearts, kidneys, and livers. Thus, the higher rates of rejection and poor long-term survival of lung transplant recipients may stem from the global immunosuppression strategies that are indiscriminately used for all solid organ grafts. Data from our laboratory, and others, have demonstrated that the unique immunoregulatory pathways of the lung may require different strategies for long-term graft survival. For example, depletion of CD8 + T cells typically contributes to the acceptance of transplanted organs. However, these cells facilitate lung allograft acceptance through interferon gamma mediated nitric oxide production. Interestingly CD8 + T cells modify and polarize eosinophils to produce nitric oxide as a means of tolerance induction. Such eosinophils also function to maintain long-term lung allograft acceptance by interfering with humoral alloimmunity. For most other organs eosinophils are suspected to contribute to graft rejection. In this review, we aim to describe the cytokine pathways involved in lung allograft rejection or tolerance, contrast such pathways to those evident in other solid organs, and discuss the need for further studies that can be used to design rational methods for altering the cytokine environment to improve lung allograft survival.

Indexed as

Graft RejectionGraft SurvivalLungLung TransplantationTransplantation ToleranceAllograftsAnimalsCD8-Positive T-LymphocytesCytokinesEosinophilsHumansOrgan SpecificityCytokines

Identifiers

PMID40958148
PMCPMC12503030

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.